Clinical Trials Browser

Phase 2 × Hormone Receptor-positive Advanced Breast Cancer × Fulvestrant × Clear all

NCT05806047 2023-04-10

Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy

Phase 2 Unknown

Hormone Receptor-positive Advanced Breast Cancer